Steinert R F, Post C T, Brint S F, Fritch C D, Hall D L, Wilder L W, Fine I H, Lichtenstein S B, Masket S, Casebeer C
Center for Eye Research, Ophthalmic Consultants of Boston, Boston, MA 02114.
Ophthalmology. 1992 Jun;99(6):853-60; discussion 860-1. doi: 10.1016/s0161-6420(92)31864-0.
Multifocal intraocular lenses (IOLs) have been designed to provide improved near visual acuity without spectacles compared with monofocal IOLs. Early studies have reported variables amounts of decreased visual acuity and contrast sensitivity with multifocal IOLs, and some patients have experienced halos and glare.
The authors performed a prospective, double-masked, multicenter evaluation of 62 patients randomized between a new zonal-progressive optic multifocal IOL and a monofocal IOL.
Mean postoperative spherical equivalent, astigmatism, and uncorrected and best-corrected distance visual acuity were similar between the two groups. Patients with a multifocal IOL achieved significantly better uncorrected near visual acuity than patients with monofocal IOLs (J3+ versus J7; P less than 0.0001). With distance correction only, mean near visual acuity was J2 versus J5- (P = 0.0001). Best-corrected near visual acuity was J1 for both groups, with 1.36 diopters (D) for the multifocal group versus 2.37 D for the monofocal group (P less than 0.0001). Regan contrast sensitivity was lower for the multifocal patients at all contrast levels, and achieved statistical significance at very low contrast (11% contrast; P = 0.0024). Fifty-two percent of patients with a multifocal IOL reported that they did not need spectacles at all or used them only for their fellow eye, compared with 25% of the patients with monofocal IOLs.
Both monofocal and multifocal implant patients were very satisfied with the results of their cataract extraction and IOL implant surgery. A small loss of contrast sensitivity with the multifocal IOL was demonstrated, consistent with theoretical predictions. The functional significance of the loss of contrast sensitivity appears to be small and counterbalanced by the advantage of improved uncorrected near visual acuity.
与单焦点人工晶状体相比,多焦点人工晶状体的设计目的是在不佩戴眼镜的情况下提高近视力。早期研究报告了多焦点人工晶状体导致视力下降和对比敏感度变化的不同程度,一些患者还出现了光晕和眩光现象。
作者对62例患者进行了一项前瞻性、双盲、多中心评估,这些患者被随机分为新型区域渐进性光学多焦点人工晶状体组和单焦点人工晶状体组。
两组术后平均球镜等效度、散光、未矫正和最佳矫正远视力相似。多焦点人工晶状体患者的未矫正近视力明显优于单焦点人工晶状体患者(J3+对J7;P小于0.0001)。仅进行远视力矫正时,平均近视力为J2对J5-(P = 0.0001)。两组的最佳矫正近视力均为J1,多焦点组为1.36屈光度(D),单焦点组为2.37 D(P小于0.0001)。在所有对比度水平下,多焦点人工晶状体患者的雷根对比敏感度均较低,在极低对比度(11%对比度;P = 0.0024)时具有统计学意义。52%的多焦点人工晶状体患者报告他们根本不需要眼镜或仅在另一只眼睛使用眼镜,而单焦点人工晶状体患者的这一比例为25%。
单焦点和多焦点人工晶状体植入患者对白内障摘除和人工晶状体植入手术的结果都非常满意。多焦点人工晶状体出现了轻微的对比敏感度下降,这与理论预测一致。对比敏感度下降的功能意义似乎较小,并被未矫正近视力提高的优势所抵消。